149 related articles for article (PubMed ID: 10799446)
1. Relevance of the viral RAK alpha gene in diagnosis of malignant versus nonmalignant tumors of the ovary and uterus.
Rakowicz-Szulczynska EM
Clin Diagn Lab Immunol; 2000 May; 7(3):360-5. PubMed ID: 10799446
[TBL] [Abstract][Full Text] [Related]
2. Prostate, breast and gynecological cancer markers RAK with homology to HIV-1.
Rakowicz-Szulczynska EM; Jackson B; Snyder W
Cancer Lett; 1998 Feb; 124(2):213-23. PubMed ID: 9500213
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical versus molecular detection of RAK antigens in breast cancer.
Kyriacou KC; Iacovou F; Adamou A; Hadjisavvas A; Rakowicz-Szulczynska EM
Exp Mol Pathol; 2000 Aug; 69(1):27-36. PubMed ID: 10891290
[TBL] [Abstract][Full Text] [Related]
4. Giant syncytia and virus-like particles in ovarian carcinoma cells isolated from ascites fluid.
Rakowicz-Szulczynska EM; McIntosh DG; Smith ML
Clin Diagn Lab Immunol; 1999 Jan; 6(1):115-26. PubMed ID: 9874674
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1-like DNA sequences and immunoreactive viral particles with unique association with breast cancer.
Rakowicz-Szulczynska EM; Jackson B; Szulczynska AM; Smith M
Clin Diagn Lab Immunol; 1998 Sep; 5(5):645-53. PubMed ID: 9729531
[TBL] [Abstract][Full Text] [Related]
6. New protein and PCR markers RAK for diagnosis, prognosis and surgery guidance for breast cancer.
Rakowicz-Szulczynska EM; Markowski M; Mackiewicz A; Karczewska A; Snyder W; McIntosh DG; Kapcinska M; Smith ML
Cancer Lett; 1997 Jan; 112(1):93-101. PubMed ID: 9029174
[TBL] [Abstract][Full Text] [Related]
7. Rak, a novel nuclear tyrosine kinase expressed in epithelial cells.
Cance WG; Craven RJ; Bergman M; Xu L; Alitalo K; Liu ET
Cell Growth Differ; 1994 Dec; 5(12):1347-55. PubMed ID: 7696183
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic evaluation of cancer antigens RAK .1. Cervical and ovarian cancer.
Rakowiczszulczynska E; Roszak A; Mackiewicz A; Markowska J; McIntosh D; Karczewska A; Godlewski D; Snyder W; Leary D; Smith M
Int J Oncol; 1996 Oct; 9(4):693-9. PubMed ID: 21541570
[TBL] [Abstract][Full Text] [Related]
9. Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, colon and other carcinomas.
Chen PF; Freedman RS; Chernajovsky Y; Platsoucas CD
Hum Antibodies Hybridomas; 1994; 5(3-4):131-42. PubMed ID: 7756578
[TBL] [Abstract][Full Text] [Related]
10. [New antigens induced by herpes simplex virus in human tumors].
Posevaia TA; Grigor'ev VV; Kosiakova NP; Barinskiĭ IF
Vopr Virusol; 1981; (2):193-5. PubMed ID: 6267821
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase.
Meyer T; Xu L; Chang J; Liu ET; Craven RJ; Cance WG
Int J Cancer; 2003 Mar; 104(2):139-46. PubMed ID: 12569567
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
[TBL] [Abstract][Full Text] [Related]
13. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
Madaule P; Gairin JE; Bénichou S; Rossier J
FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
[TBL] [Abstract][Full Text] [Related]
14. Exploring Rak tyrosine kinase function in breast cancer.
Yim EK; Siwko S; Lin SY
Cell Cycle; 2009 Aug; 8(15):2360-4. PubMed ID: 19597351
[TBL] [Abstract][Full Text] [Related]
15. [Distribution of oncotrophoblast antigens defined by monoclonal antibodies].
Inoue R
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1837-43. PubMed ID: 3209911
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].
Sevelda P; Salzer H; Dittrich C; Spona J
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):769-73. PubMed ID: 3865860
[TBL] [Abstract][Full Text] [Related]
17. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas.
Fogel M; Gutwein P; Mechtersheimer S; Riedle S; Stoeck A; Smirnov A; Edler L; Ben-Arie A; Huszar M; Altevogt P
Lancet; 2003 Sep; 362(9387):869-75. PubMed ID: 13678974
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors.
Scorilas A; Chiang PM; Katsaros D; Yousef GM; Diamandis EP
Gene; 2003 May; 310():79-89. PubMed ID: 12801635
[TBL] [Abstract][Full Text] [Related]
19. Characterization of HIV-1 neutralization escape mutants.
McKeating JA; Gow J; Goudsmit J; Pearl LH; Mulder C; Weiss RA
AIDS; 1989 Dec; 3(12):777-84. PubMed ID: 2483618
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line.
Chang K; Pastan I
Int J Cancer; 1994 Apr; 57(1):90-7. PubMed ID: 8150545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
